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Summary
Polycomb repressive complexes (PRC1 and PRC2) are epigenetic
regulators that act in coordination to influence multiple cellular
processes including pluripotency, differentiation, cancer and
senescence. The role of PRCs in senescence can be mostly
explained by their ability to repress the INK4/ARF locus. CBX7 is
one of five mammalian orthologues of Drosophila Polycomb that
forms part of PRC1. Despite the relevance of CBX7 for regulating
senescence and pluripotency, we have a limited understanding of
how the expression of CBX7 is regulated. Here we report that the
miR-9 family of microRNAs (miRNAS) downregulates the expres-
sion of CBX7. In turn, CBX7 represses miR-9-1 and miR-9-2 as part
of a regulatory negative feedback loop. The miR-9/CBX7 feedback
loop is a regulatory module contributing to induction of the
cyclin-dependent kinase inhibitor (CDKI) p16INK4a during senes-
cence. The ability of the miR-9 family to regulate senescence
could have implications for understanding the role of miR-9 in
cancer and aging.
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Introduction
The majority of the mammalian genome is transcribed but only 2% of
it is translated. The differential between the transcribed and translated
genomes highlights the importance of noncoding RNAs in mediating
and regulating physiological processes (Amaral et al., 2008). Micro-
RNAs (miRNAs) are small noncoding RNAs that bind to complementary
sequences in their target mRNAs and either block their translation or
promote their turnover (Bartel, 2004, 2009). As each miRNA can target
multiple mRNAs, they can have profound effects on the patterns of
gene expression and individual miRNAs have been shown to influence
a broad range of cellular processes, including development, cancer,
senescence and aging (Ambros, 2004). This functional pleiotropism has
given rise to the concept of ‘miRNA expression signatures’, which differ
depending on the tissue, cell type and the pathology. For example,
miR-9 is expressed at high levels in neural tissues and is essential for
the development of the brain (Delaloy et al., 2010; Uchida, 2010). miR-
9 plays a critical role in regulating the proliferation of neural
progenitors and, not surprisingly, has been implicated in the develop-
ment of different types of brain tumour, such as medulloblastoma and
glioblastoma (Ferretti et al., 2009; Malzkorn et al., 2010). Several miR-
9 target genes have been described that might play a role in this
context. One of the most prominent is the nuclear receptor NR2E1
(also called TLX), which is essential for the proliferation and self-
renewal of neural stem cells (NSC) and brain tumour stem cells (BTSC)
(Liu et al., 2010; Zhu et al., 2014). Besides its role in the brain, miR-9
also influences normal physiology and tumour development in other
tissues. For example, miR-9 is highly expressed in primary breast
cancers, where it promotes angiogenesis and metastasis (Ma et al.,
2010). In contrast, downregulation of miR-9 has been reported in other
cancer types, such as leukaemias (Emmrich et al., 2014), suggesting
cell- and tumour-specific effects that might be explained by different
expression levels of its targets.
Cellular senescence is a highly stable cell cycle arrest triggered by
replicative exhaustion or in response to different stresses (Collado et al.,
2007; Kuilman et al., 2010). Senescence was first described in vitro, but
its relevance as a physiological process in vivo is increasingly clear.
Senescence induced in response to oncogenes has been recognized as a
tumour suppressor mechanism (Kuilman et al., 2010; Perez-Mancera
et al., 2014). In addition, senescence also has roles in early embryo-
genesis and aging amongst other physiological processes (Munoz-Espin
& Serrano, 2014). The INK4/ARF locus encodes three proteins involved
in the implementation of senescence: the cyclin-dependent kinase
inhibitors (CDKI) p16INK4a and p15INK4b and ARF, a regulator of p53 (Gil
& Peters, 2006; Kim & Sharpless, 2006). In proliferating cells, the
expression of the INK4/ARF locus is tightly controlled by the action of
Polycomb repressive complexes (PRCs). The PRC1 complex is comprised
of four core subunits, which include orthologues of Drosophila
Polycomb, Posterior sex combs, Polyhomeotic and Sex combs extra
(Simon & Kingston, 2009). CBX7 is one of five mammalian orthologues
of Drosophila Polycomb. As a component of PRC1, CBX7 represses the
INK4/ARF locus (Gil & O’Loghlen, 2014). Indeed, CBX7 was first
identified in a screen for bypass of replicative senescence (Gil et al.,
2004). More recently, CBX7 was recognized as the main orthologue of
Drosophila Polycomb implicated in maintaining the self-renewal of
embryonic stem (ES) cells (Morey et al., 2012; O’Loghlen et al., 2012).
In ES cells, the miR-125 and miR-181 families regulate CBX7 expression
levels and impact on the balance between self-renewal and differen-
tiation (O’Loghlen et al., 2012).
Little is known about how the expression and function of CBX7 are
regulated. Here, we report that the miR-9 family of miRNAs regulates
CBX7 expression and controls cellular senescence. As part of a negative
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regulatory feedback loop, CBX7 regulates miR-9 by binding to its
promoter region and repressing its transcription. The miR-9/CBX7
feedback loop could behave as a regulatory module contributing to
upregulate p16INK4a at the onset of senescence.
Results
miR-9 regulates CBX7
We recently carried out a screen to identify miRNAs that regulate CBX7
using a mouse Cbx7 30UTR reporter and a miRNA expression library
comprising 371 miRNAs (O’Loghlen et al., 2012). The screen yielded
miRNAs belonging to the miR-125 and miR-181 families, and their
ability to modulate CBX7 was confirmed in a number of ways
(O’Loghlen et al., 2012). We subsequently took advantage of target
prediction software (TARGETSCAN and microRNA.org) (Betel et al., 2008;
Friedman et al., 2009), which in addition to correctly predicting the
target sites for miR-125 and miR-181 in CBX7 identified a potential
target site for miR-9 in the 30UTR. Manual analysis identified a putative
second target site for miR-9 (Fig. 1A). We decided to investigate
whether miR-9 regulates CBX7 using a reporter vector in which the
30UTR of human CBX7 is inserted into a luciferase reporter vector
(psiCHECK2-CBX7-30UTR). Expression of miR-9 repressed the luciferase
activity of the reporter suggesting that miR9 did indeed target human
CBX7 (Fig. 1B). Having previously identified miR-181 as a regulator of
CBX7 in senescence and stem cell regulation (O’Loghlen et al., 2012),
we used it as a control for subsequent experiments. Next, we mutated
the two miR-9 sites to generate the CBX7-30UTR 9.1/2 reporter. While
miR-181 was still able to downregulate the CBX7-30UTR 9.1/2 reporter,
miR-9 expression did not decrease luciferase activity, suggesting that
miR-9 regulates CBX7 expression by targeting these sites in the 30UTR
(Fig. 1C). We confirmed that the vectors used resulted in expression of
miR-9 and miR-181, respectively (Fig. S1). In addition, transient
transfection of IMR90 cells with either synthetic miR-9 or miR-181
mimetics caused a reduction in the endogenous CBX7 levels as
determined by qRT–PCR (Fig. 1D). A similar result was observed after
infecting IMR90 cells with retroviral vectors encoding the miR-9 and
miR-181 precursors (data not shown). Together, these results suggest
that miR-9 regulates CBX7 expression.
CBX7 regulates miR-9-1 and miR-9-2
MicroRNAs are involved in fine-tuning patterns of gene expression, often
through regulatory feedback mechanisms between the miRNAs and
their target genes (Zhao et al., 2009; Overhoff et al., 2014). To test
whether CBX7 also regulates miR-9, we analysed chromatin immuno-
precipitation (ChIP)-Seq data sets that we have reported elsewhere
(Pemberton et al., 2014). ChIP-Seq of various PRC1 components,
including CBX7, revealed binding at two of the three loci coding for
miR-9 family genes (Fig. 2A,B). The three microRNAs, miR-9-1, 9-2 and
9-3, are encoded by distinct loci on chromosomes 1, 5 and 15,
respectively, and share the same mature sequence. Little is known about
miR-9-3, and it did not register as a PRC1 target in the ChIP-Seq analysis.
Additional ChIP experiments using qPCR and primer sets that span the
relevant genomic DNA confirmed that CBX7 binds specifically to the
regions adjacent to or upstream of miR-9-1 and miR-9-2 (Fig. 2A,B).
These results implied that CBX7 could be transcriptionally repressing
miR-9 expression. Consistent with this idea, over-expression of mouse
Cbx7 caused down-regulation of miR-9 (Fig. 2C, Fig. S2A), whereas
shRNA-mediated knockdown of CBX7 resulted in up-regulation of miR-9
(Fig. 2D, Fig. S2B). To further confirm these results, we looked into how
knockdown of CBX7 affected the expression of the primary miRNA
transcripts (pri-miRNAs) of the miR-9 family. Confirming the ChIP
data, knockdown of CBX7 resulted in upregulation of pri-miR-9-1 and
(A)
(B) (C) (D)
Fig. 1 miR-9 targets human CBX7. (A) Schematic representation of CBX7 mRNA. Bioinformatics analysis for miRNAs targeting the 30UTR of human CBX7 was performed
using manual analysis and the Targetscan and microRNA.org resources. Potential target sites for miR-125, miR-9 and miR-181 in the 30UTR of human CBX7 are indicated.
Nucleotide positions refer to the ENST00000216133 transcript. (B) A luciferase reporter assay shows that miR-9 also regulates the 30UTR of human CBX7. (C) Mutation of
two sites in the 30UTR makes CBX7 30UTR reporter resilient to miR-9 regulation. A luciferase reporter assay similar to (B) was carried out using either a CBX7 30UTR wt
reporter (black bars) or a CBX7 30UTR 9.1/2 reporter (with two miR-9 sites mutated, orange bars). Statistical significance was calculated using two-tailed Student’s t-tests,
**P < 0.01; *P < 0.05; n.s. nonsignificant. (D) Transfection of a miR-9 mimic downregulates CBX7 expression, as shown by qRT–PCR. miR-181 is used as a positive control
for downregulating CBX7.
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pri-miR-9-2, without affecting pri-miR-9-3 expression (Fig. 2E). These
results imply the existence of an autoregulatory network between miR-9
and CBX7, where miR-9 downregulates CBX7 and CBX7 transcription-
ally represses miR-9.
The expression of miR-9 is induced during replicative
senescence
Next, we investigated the expression of miR-9 during senescence. To this
end, we used two different human fibroblast strains, IMR90 and WI38.
Using RNA obtained from low passage (young) and late passage
(senescent) fibroblasts, we confirmed that the expression of the mRNA
encoding for p16INK4a increased during senescence, as expected. This
correlated with a decrease in CBX7 mRNA levels and an induction of
miR-9 in both fibroblast strains (Fig. 3). The above results suggest that
miR-9 might have a role in fine-tuning CBX7 expression during
replicative senescence.
The expression of miR-9 causes senescence
Given that miR-9 expression resulted in the downregulation of CBX7
mRNA levels, and CBX7 has been linked with senescence regulation, we
decided to test the effect that miR-9 has on senescence. Infection of
IMR90 cells with a retroviral vector encoding miR-9-1 led to reduced cell
growth, analogous to the effects of miR-181. This manifested as a
decrease in colony formation as judged by crystal violet staining (Fig. 4A)
and reduced cell numbers (Fig. 4B). Similarly, transfection of synthetic
miR-9 oligomers caused a decrease in cell numbers (data not shown) and
BrdU incorporation, whereas antagomirs targeting miR-9 had the
converse effect (Fig. 4C). To assess whether this arrest has characteristics
of senescence, we infected IMR90 cells with a vector encoding miR-9-1
and observed an increase in the percentage of cells that were positive for
SA-b-Gal staining and also an increase in the percentage of cells
presenting senescence-associated heterochromatin foci (SAHFs, Fig. 4D),
but did not detect a significant increase in the induction of SASP
(A)
(B)
(C) (D) (E)
Fig. 2 CBX7 represses the expression of
miR-9-1 and miR-9-2. (A, B) CBX6, CBX7
and CBX8 associate with miR-9-1 (A) and
miR-9-2 (B). ChIP-seq for CBX6, CBX7 and
CBX8 was performed in Hs68 human
fibroblasts (left panel). Their binding
profiles on miR-9-1 (A) and miR-9-2 (B) are
shown. The location of primer sets used
(primer sets PS1.1, PS3.1 and PS4.1 for
miR-9-1 and PS1.2, PS2.2, PS3.2 and PS4.2
for miR-9-2) is also depicted (left). ChIP in
human fibroblast cells confirming that
CBX7 binds to miR-9-1 (A) and miR-9-2 (B)
is shown (right). (C) CBX7 overexpression
reduces miR-9 levels in IMR90 cells as
shown by qRT–PCR. (D) CBX7 knockdown
results in an increase in miR-9 as assessed
by qRT–PCR. (E) Knockdown of CBX7
results in upregulated levels of pri-miR-9-1
and pri-miR-9-2 as assessed by qRT–PCR.
Statistical significance was calculated using
two-tailed Student’s t-tests, **P < 0.01;
*P < 0.05; n.s. nonsignificant.
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components (Fig. S3A). However, we did not detect significant cell death
(data not shown) suggesting senescence. To explore how miR-9 caused
senescence, we determined the effect that miR-9 had on the expression
of key senescence effectors such as p16INK4a, p21CIP and p53 using
immunofluorescence and high-throughput microscopy. Expression of
miR-9 in IMR90 cells induced p16INK4a (Fig. 4E) without affecting p21CIP
(Fig. S3B) or p53 (Fig. S3C). The induction of p16INK4a by miR-9 was
confirmed by transfecting synthetic miR-9 (Fig. S3D). Together, these
results suggest that increased miRNA-9 levels alter the equilibrium of the
miR9/CBX7 regulatory loop resulting in upregulation of p16INK4a and
senescence.
miR-9 induces senescence in a CBX7-dependent fashion
To substantiate the role of CBX7 and p16INK4a in miR-9-induced
senescence, we first generated IMR90 cells overexpressing murine CBX7
(Cbx7). Expression of miR-9 or miR-181 resulted in a significant arrest
(Fig. 5A) and a decrease in BrdU incorporation (Fig. 5B) in the control cells,
but not in cells overexpressing CBX7. Notably, while expression of miR-9
increased the percentage of IMR90 cells positive for SA-b-Gal (Fig. 5C)
and SAHF (Fig. 5D), expression of CBX7 blunted the ability of miR-9 to
induce senescence. Importantly, these phenotypes correlated with
decreased INK4a levels in cells overexpressing CBX7 (Fig. 5E).
The arrest caused by miR-9 is dependent on p16INK4a
Next, we took advantage of the Leiden strain of human fibroblasts that
carry a mutation that functionally inactivates both copies of p16INK4a
(Brookes et al., 2002). Immunostaining revealed that the levels of the
altered protein in Leiden fibroblasts are lower than those of wild-type
p16INK4a in IMR90 cells (Fig. S4A). The effect that miR-9 expression had
on proliferation of IMR90 fibroblasts, as evaluated by crystal violet
staining (Fig. S4B) and BrdU incorporation (Fig. S4B), was mitigated in
the Leiden strain of fibroblasts, suggesting that they depended on
p16INK4a. To confirm that p16INK4a mediates the arrest caused by miR-9,
we derived cells in which p16INK4a expression was knocked down taking
advantage of shRNA (Fig. 6A). While expression of miR-9 in IMR90 cells
caused growth arrest (Fig. 6B) and increased the number of SA-b-Gal
positive cells (Fig. 6C), the same was not observed in IMR90 shp16 cells.
Taken together, these findings imply that miR-9 and CBX7 are involved
in a regulatory network that controls p16INK4a expression to regulate
senescence.
Discussion
In recent years, there has been considerable progress in understanding
the mechanisms by which PRCs are recruited to their target genes and
regulate gene expression (Luis et al., 2012; Gil & O’Loghlen, 2014).
Much less is known about how the function and expression of the PRCs
and their components are controlled. The regulation of CBX7 is
particularly interesting because CBX7 is implicated in senescence (Gil
et al., 2004) and cancer (Bernard et al., 2005; Scott et al., 2007;
Pallante et al., 2008; Karamitopoulou et al., 2010). In addition, CBX7
levels and consequently the composition of PRC1 complexes change
dramatically during ES cell differentiation (Morey et al., 2012; O’Loghlen
et al., 2012). In a screen for transcription factors that regulate CBX7
(O’Loghlen et al., 2014), we identified E2F family members and the
nuclear receptor NR2E1 as positive regulators of CBX7 expression
(O’Loghlen et al., 2014). Previously, we also described how miRNAs of
the miR-125 and miR-181 families negatively regulate CBX7 during ESC
differentiation (O’Loghlen et al., 2012). Here, we add miR-9 as another
miRNA family that contributes to the regulation of CBX7. Although our
results suggest that miR-9 directly controls the stability of CBX7 mRNA,
further experiments are needed to fully discard an indirect regulation or
miR-9 inhibiting the translation of CBX7.
Interestingly, miR-9 levels are upregulated during replicative senes-
cence, suggesting it might contribute to fine-tune the induction of
p16INK4a in that context. Ectopic expression of miR-9 induces a
senescence-like arrest, dependent on p16INK4a induction (Fig. 6D). Cells
expressing miR-9 became arrested and SA-b-Gal positive, developed
SAHFs and upregulated p16INK4a expression. However, we could not
detect an activation of p53 or p21 or significant induction of several
SASP components. This is reminiscent of the arrest caused by JMJD3
overexpression, which also results in p16INK4a induction in the absence of
activation of p53 (Barradas et al., 2009). Moreover, it has been
described that p16INK4a induction is sufficient to trigger senescence in
the absence of SASP (Coppe et al., 2011), similar to what we observe
upon miR-9 expression.
(A)
(B)
Fig. 3 miR-9 expression is upregulated
during replicative senescence of human
fibroblast. The levels of miR-9 (left), INK4a
mRNA (coding for p16INK4a, centre) and
CBX7 mRNAs (right) were analysed by qRT–
PCR comparing either IMR90 (A) or WI38
(B) young and senescent cells.
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MicroRNAs often fine-tune patterns of gene expression as part of
regulatory feedback loops; the aforementioned regulation ofCBX7bymiR-
181 and miR-125 in ESCs is such an example (O’Loghlen et al., 2012).
Similarly, a study on human mammary epithelial cells (HMECS) identified
several miRNAs that regulate p16INK4a expression (Overhoff et al., 2014)
and suggested that they might target different components of PRC1 and
PRC2. In addition, it has been shown that the miRNA let-7 can downreg-
ulate HMGA2 levels and is responsible for the induction of p16INK4a during
the aging of adult stem cells (Nishino et al., 2008). Here, we described an
autoregulatory loop involving CBX7 and miR-9 that could contribute to
fine-tune the induction of p16INK4a during replicative senescence.
The miR-9 family affects different physiological processes. miR-9 can
inhibit cell proliferation and migration in the context of cancer (Selcuklu
et al., 2012; Yu et al., 2013), although its effects can be both cell type
and context dependent (Ma et al., 2010). miR-9 may also have a role
during aging. While miR-9 can target prelamin A, thereby preventing the
expression of progerin in models of Hutchinson-Gilford progeria
syndrome (HPGS) (Jung et al., 2012), other studies (Olivieri et al.,
2013) and this report have observed that the expression of miR-9 can
increase during senescence. The ability of miR-9 to downregulate CBX7
expression causing p16INK4a induction and senescence could therefore
provide an explanation for the role of miR-9 in cancer and aging.
As with many other miRNAs, miR-9 targets multiple genes. Some of
these targets can potentially explain the physiological effects of miR-9.
For example, the ability of miR-9 to inhibit cell proliferation has been
linked to downregulation of MTHFD2 expression in cancer cells (Selcuklu
et al., 2012) or TLX/NR2E1 in neural stem cells (Liu et al., 2010; Zhu
et al., 2014). The regulation of CXCR4 by miR-9 has also been invoked
to explain the effect of miR-9 on cell growth (Yu et al., 2013). In
addition, miR-9 can regulate NF-KB1, affecting cell migration (Liu et al.,
(A)
(C)
(E)
(D)
(B)
Fig. 4 miR-9 expression triggers cellular
senescence. (A, B) Overexpression of miR-9-
1 results in decreased proliferation of
IMR90 cells. IMR90 cells infected with miR-
9-1 (or miR-181a/b, or control vectors)
were selected, and cells seeded at low
density. Plates were stained with crystal
violet 2 weeks later. (A) Representative
plates and (B) quantification of crystal violet
staining (average of five independent
experiments) are shown. Statistical
significance was calculated using two-tailed
Student’s t-tests, ***P < 0.001. (C) miR-9
triggers arrest of IMR90 cells. BrdU
incorporation was assessed by IF in IMR90
cells transfected with miR-9 or miR-181
mimics or with anti-miR-9. (D) IMR90 cells
infected with the indicated vectors were
subjected to SA-b-Gal (left) and DAPI
staining (right) to visualize SAHFs.
Representative images (top) and
quantification of the percentages positive
for SA-b-Gal or containing SAHFs are
shown (bottom). (E) Expression of miR-9
induces p16INK4a. The levels of p16INK4a
were assessed by quantitative IF in IMR90
cells infected with a retroviral vector
expressing miR-9.
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(B)(A)
(C)
(D) (E)
Fig. 5 miR-9-induced senescence is
rescued by CBX7 overexpression.
(A) Control and IMR90 cells overexpressing
murine CBX7 (Cbx7) were infected with
pMSCV-miR-9-1, miR-181a/b or control
vectors, cells selected and seeded at low
density. Crystal violet stained plates are
shown. (B–D) Cells derived from the same
experiments were used to measure (B) BrdU
incorporation, (C) SA-b-Gal positive cells
and (D) the percentage of cells showing
SAHFs. (E) The levels of the INK4a transcript
(encoding for p16INK4a) were analysed by
qRT–PCR in the indicated cells.
(A)
(D)
(B) (C)
Fig. 6 miR-9-induced senescence is p16INK4a-dependent. (A) IMR90 cells were infected with a vector knocking down p16INK4a expression (shp16) or the corresponding
control (vector). The derived cells were subsequently infected with viruses expressing miR-9 or controls. The expression of p16INK4a was assessed by IF. Representative
pictures (left) and quantification (right) is shown. (B, C) Knocking down p16INK4a expression suppressed miR-9-induced senescence. The percentage of (B) cells incorporating
BrdU and (C) cells positive for SA-b-Gal staining is shown. (D) Scheme depicting the regulatory network formed by CBX7 and miR-9 to control p16INK4a expression and
regulate senescence.
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2012), and E–cadherin (Ma et al., 2010), explaining its role in regulating
metastatic growth. It would clearly be interesting to determine how the
regulatory module involving CBX7 and miR-9 contributes to these
physiological processes and whether it influences aging.
Experimental procedures
Cell culture and retroviral infection
HEK293T, Hs68, WI38 and IMR90 cells were obtained from the ATCC.
Leiden human fibroblasts have been previously described (Brookes et al.,
2002). Cells were maintained in Dulbecco’s modified Eagle’s medium
(Invitrogen, Paisley, UK) with 10% foetal bovine serum (PAA,
Amersham, UK) and 1% antibiotic–antimycotic solution (Invitrogen,
Paisley, UK). Methods used for retrovirus production and infection have
been described previously (Acosta et al., 2008).
Plasmids
Plasmids encoding for different microRNAs and its corresponding control
were obtained from the miR-Vec library (Voorhoeve et al., 2006). The
CBX7 reporter plasmid has been described before (O’Loghlen et al.,
2012) and was used to derive the CBX7 30UTR 9.1/2 reporter by Gibson
assembly. Retroviral vectors for CBX7 overexpression and for shRNA-
mediated knockdown of CBX7 and p16 have been described previously
(O’Loghlen et al., 2012).
miRNA reverse transfection and luciferase assay
For the luciferase assay, HEK293T cells were reverse transfected using
polyethylenimine (PEI; Sigma, St Louis, MO, USA) to individually
transfect our positive clones from the miR library in a 96-well plate
format. A 9:1 ratio of miR-Vec to luciferase reporter construct was
used. miR-Vec-Ctrl was used as control vector. A 3:1 ratio of PEI to
DNA was used, and after incubation of reagent–DNA complexes for
30 min, cells were added. Firefly and Renilla luciferase activities were
measured using the Dual-Luciferase Reporter Assay system (Promega,
Madison, WI, USA) 48 h after transfection.
miRNA transfection
IMR90 cells were transfected with 30 nM miRNA or anti-miRNA
antagomir in 6-well plates. A 3.5% solution of HiPerFect transfection
reagent (QIAGEN, Valencia, CA, USA) was prepared in serum-free
DMEM and then mixed with the miRNA or anti-miRNA. The mix was
incubated for 30 min at room temperature and then added to the cells.
Medium was changed on the following day, and cells were either fixed
for immunofluorescence or harvested for RNA extraction 24–96 h later.
A scrambled siRNA (AllStars) or Silencer Select Negative Control #1 and
#2 siRNA (Ambion, Carlsbad, CA, USA) were included as negative
controls in most experiments.
Quantitative RT–PCR analysis
Total RNA and miRNAs were extracted using miRCURY RNA isolation kit
(Exiqon, Vedbaek, Denmark) or High Pure miRNA Isolation kit and High
Pure RNA Isolation Kit (Roche, Basel, Switzerland). cDNAs were
generated using SuperScript II reverse transcriptase (Invitrogen, Paisley,
UK). For miRNA reverse transcription, TaqMan miRNA reverse transcrip-
tion kit was used with specific miRNA primers. PCR reactions were
performed in an Opticon 2 Real-Time PCR Detection System (Biorad,
Hercules, CA, USA) using Power SYBR Green Master Mix or TaqMan
Universal PCR Master Mix (Applied Biosystems, Carlsbad, CA, USA).
Expression was normalized to human ribosomal protein S14 (RPS14) or
Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) for mRNAs and
RNU6B or U6snRNA for miRNAs. Taqman probes used in this study were
acquired from Life Technologies and include CBX7 (Hs00545603_m1),
TBP (4333769F), Hsa-miR-9 (A583), RNU6B (1093), U6snRNA (1973).
Primers used for RT–PCR are as follows: mouse Cbx7 (For:
GGATGGCCCCCAAAGTACAG; Rev: TATACCCCGATGCTCGGTCTC),
INK4a (For: CGGTCGGAGGCCGATCC
AG; Rev: GCGCCGTGGAGCAGCAGCAGCT), IL-8 (For: GAGTGGACC
ACACTGCGCCA; Rev: TCCACAACCCTCTGCACCCAGT), IL-6 (For:
CCAGGAGCCCAGCTATGAAC; Rev: CCCAGGGAGAAGGCAACTG),
CXCL1 (For: GAAAGCTTGCCTCAATCCTG; Rev: CACCAGTGAG
CTTCCTCCTC), RPS14 (For: TCACCGCCCTACACATCAAACT; Rev:
CTGCGAGTGCTGTCAGAGG), Pri-miR9-1 (For ACTGTGACTCCTACC
TGTGC; Rev ATAACCCCATACACTGCGCA), Pri-miR9-2 (For: TGCC
GGAGATTACTTGCTGA; Rev: TTCCTCTTGCCAGACTCCAG), Pri-miR9-3
(For: CCACAGAGCCGTCATAAAGC; Rev CAGGAAAGAGGAGGAC
TGGG), GAPDH (For: ACCACAGTCCATGCCATCAC; Rev: TCCACCAC
CCTGTTGCTGTA).
Chromatin immunoprecipitation
Chromatin immunoprecipitation experiments were performed as
described previously (Pemberton et al., 2014). Immunoprecipitation of
cross-linked chromatin was conducted with CBX7 antibody (ab21873;
Abcam, Cambridge, UK). After immunoprecipitation, DNA was extracted
using the QIAquick PCR purification kit (Qiagen) and an aliquot amplified
by real-time qPCR using the following primers: hsa-miR-9-1. PS1.1 (For:
TTCTCGAATGCTGTGGACTG; Rev: AGAAGACGGTCTGGAAAGCA);
PS3.1 (For: GCGCAGTGTATGGGGTTATT; Rev: GCGGGGTTGGTT
GTTATCTT); PS4.1 (For: TGTCTGTGTGCCTGAAGAGG; Rev: GAATCCA
CCCTTTCCCAAAT). Hsa-miR-9-2. PS1.2 (For: CTGCCAAATCATCAG
CTTCA; Rev: TTCCTCCCATTTCAGTCTGG); PS2.2 (For: AGGCCGCTTT
ACAGGGTTAT; Rev: GCAAATACATTGCCCGAGTT); PS3.2 (For: GCC
TCCCCTCTTGTCAAAGT; Rev: AGGCAAGACAGACCCTCAGA); PS4.2
(For: ATGACAGGGCCAATGAG; Rev: CCGAGGGCCAGTGACTATTA).
To confirm target enrichment, each PCR product was evaluated first by
standard end point PCR.
ChIP-seq and bioinformatics analysis
Parallel ChIP experiments were performed using approximately 5 lg of
antibody with 500 lg chromatin. The recovered material was pooled
and concentrated to a minimum of 0.2 lg lL1. Input DNA was used
as control for the ChIP-seq analysis. Library preparation and Solexa
genome-wide sequencing was performed as recommended by the
manufacturer. The alignments were performed using NOVOALIGN
(version 2.07.14; http://novocraft.com) allowing for a single mismatch
per read. Duplicates were removed using the PICARD MARKDUPLICATES
program (Picard-tools package version 1.48; http://picard.source-
forge.net), and peak calling was performed with MACS (version
1.4.0rc2; 46).
BrdU assay and crystal violet staining
BrdU labelling was performed for 24 h. Crystal violet staining was
performed as previously described (Acosta et al., 2008).
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SA-b-Galactosidase staining and SAHF quantification
SA-b-Galactosidase staining and quantification was performed as
previously described (Acosta et al., 2008). For SAHF quantification, cells
were stained with DAPI and the nuclei of at least 100 cells per condition
were assessed.
Immunofluorescence and immunoblotting
The following antibodies were used: BrdU (A21303; Invitrogen, Paisley,
UK), p16INK4a (JC-8, CRUK), p53 (sc-126, DO1; Santa Cruz Biotechnol-
ogy, Wembley, UK) and p21CIP (CP74, Sigma). Immunofluorescence was
performed using an automated high-throughput microscope (InCell
Analyzer 1000; GE Healthcare, Amersham, UK). Image processing and
quantification was performed using INCELL INVESTIGATOR software (GE).
miRNA target prediction
Bioinformatics miR prediction on the 30UTR of human CBX7 was
performed using the TargetScan (http://www.targetscan.org) and
MicroRNA.org (http://www.microrna.org/microrna/home.do) websites.
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